A few weeks ago I published my own coronary CT angiogram results, and the top comment underneath was the same question asked over and over: how did you do it? One person said the episode felt like a bait and switch. Fair enough. That episode was about the results. This one is about the protocol behind them, and about whether the headline number was ever real in the first place.
Here is the tension. A single platform, HeartFlow, read my two scans and reported a 48% drop in total plaque volume. Two other platforms read the same images from the same scanner on the same days and disagreed, one finding almost no change and one finding a 20% increase. I could have shown you only the flattering result and built something to sell off the back of it. Instead I am showing you all three, explaining which one I anchor to and why, and telling you about the prescription medication I have started despite that 48% headline. The interesting story here is not the number. It is what the disagreement between these tools tells us about how much confidence any of us should place in short-interval plaque tracking.
What We Cover:
- How I ended up with plaque at 38 despite a decade of eating well, and why cumulative exposure matters more than today’s cholesterol reading
- The exact nutrition, training, sleep, and supplement protocol I ran between the two scans, including what I deliberately did not take
- Three platforms, one heart: 11.5, 60, and 74 cubic millimetres of plaque from the same images
- Why one company says there is a grain of rice in my arteries and another says six
- Which analysis Dr Matthew Budoff trusts, and the published warning about AI overestimation sitting behind his answer
- The 25-point percentile swing that comes purely from whose reference population you stand next to
- Why I started a PCSK9 inhibitor at an ApoB of 70 to 80, and how I chose between Repatha and a statin
- The minimum interval the American College of Cardiology recommends between serial scans, and why mine was too short
If there is one thing to take from this, it is that all three analyses agreed on what actually matters: my plaque burden is low and it is not progressing rapidly. The headline was never the point. Be sceptical of dramatic short-interval scan results, including mine.
- The Question Everyone Asked (00:00)
- Housekeeping, and Why I Track This (00:55)
- How Serial CT Angiograms Work (01:45)
- Two Scans, Three Analyses (02:25)
- How Did I Get Plaque in the First Place? (03:55)
- Cumulative Exposure and Area Under the Curve (04:40)
- What REACT Found in Men in Their Thirties (05:50)
- Why ApoB Is Not the Whole Story (07:10)
- Genetics, and How Much of Risk Is Polygenic (08:20)
- The Counterfactual I Can Never Test (10:25)
- GLAGOV, and How Low Is Low Enough (11:05)
- My Nutrition Protocol (12:25)
- You Do Not Have to Eat Like Me (14:20)
- Training, Padel, and VO2 Max (15:30)
- Sleep, and the Only Lever I Have (17:00)
- The Supplements I Was Deliberately Not Taking (19:10)
- Not Taking Life Too Seriously (20:35)
- Three Platforms, Three Different Answers (22:10)
- A Grain of Rice, or Six (24:20)
- Which Direction Was It Going? (25:20)
- Why the Platforms Disagree (27:10)
- Which Number Dr Matthew Budoff Trusts (28:50)
- The Miami Heart Study and AI Overestimation (29:40)
- Where I Actually Sit for My Age (31:35)
- The Percentile That Moves 25 Points (33:20)
- Plaque Composition, and Signs of Hardening (35:40)
- The Medication I Started, and Why (37:20)
- Why One Drug Is Enough (40:55)
- PCSK9 Inhibitor Versus Statin (41:55)
- Statin Side Effects, Honestly (43:15)
- Lurochol, Repatha, and Outcome Data (44:35)
- Aged Garlic Extract (45:25)
- Three Takeaways (47:15)
- Be Sceptical of Short-Interval Scans (48:50)
Referenced Episodes
- My Coronary Plaque Dropped 48% in 16 Months: What the AI Scan Actually Showed | Dr Campbell Rogers
- Can Supplements Reverse Your Atherosclerosis? Testing 8 Options Against the Evidence
- Can You Reverse Atherosclerosis With Diet | What 6 Major Clinical Trials Reveal | Simon Hill
- Do I Have Heart Disease? My Heart Scan Results | Dr Thomas Dayspring and Dr Dan Soffer | EP #372
Resources and links:
- Prevalence of Silent Atherosclerosis across Adult Life
- Genetics of coronary artery disease: discovery, biology and clinical translation
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
- Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial
- Portfolio Dietary Pattern and Cardiovascular Disease: A Systematic Review and Meta-analysis of Controlled Trials
- Machine Learning Framework to Identify Individuals at Risk of Rapid Progression of Coronary Atherosclerosis: From the PARADIGM Registry
- Coronary Plaque Volume in an Asymptomatic Population: Miami Heart Study at Baptist Health South Florida
- Progression of coronary calcium and incident coronary heart disease events: MESA (Multi-Ethnic Study of Atherosclerosis)
- Quantitative assessment of coronary plaque volume change related to triglyceride glucose index: The Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography IMaging (PARADIGM) registry
- Effects of Statins on Coronary Atherosclerotic Plaques: The PARADIGM Study
- Low-Attenuation Noncalcified Plaque on Coronary Computed Tomography Angiography Predicts Myocardial Infarction: Results From the Multicenter SCOT-HEART Trial (Scottish Computed Tomography of the HEART)
- Impact of statins on serial coronary calcification during atheroma progression and regression
- 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
- Distribution of Coronary Artery Calcium by Age, Sex, and Race Among Patients 30-45 Years Old
- Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials
- N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects
- Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis
- Do statins impair cognition? A systematic review and meta-analysis of randomized controlled trials
- Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- Cognitive Function in a Randomized Trial of Evolocumab
- Aged Garlic Extract Reduces Low Attenuation Plaque in Coronary Arteries of Patients with Metabolic Syndrome in a Prospective Randomized Double-Blind Study
- Quantitative Coronary Plaque Analysis in Clinical Practice: 2025 ACC Scientific Statement: A Report of the American College of Cardiology
Subscribe and stay connected:
Subscribe to The Proof on YouTube, Apple Podcasts or Spotify to ensure you never miss an episode. And don’t forget to follow me on Instagram and X for more insights and updates.
This episode is brought to you by:
38TERA
Consider 38TERA’s DMN prebiotic supplement a daily multivitamin for your gut. Formulated by yours truly and gastroenterologist Dr Will Bulsiewicz. Use code THEPROOF for a discount at checkout.
38Tera ships to the United States, Australia, and New Zealand.
Eight Sleep
Upgrade your sleep with the Pod 6 by Eight Sleep. Clinically validated to deliver up to 1 extra hour of quality sleep per night through temperature control and biometric tracking. Use code THEPROOF at eightsleep.com/theproof for up to $200 off. You get 30 days to try it at home and return it if you don’t love it.
Eight Sleep ships to the U.S. (excluding Alaska, Hawaii, and territories), Canada, Mexico, most of the EU, the U.K., Australia, the UAE, Saudi Arabia, and Switzerland.
IM8
With 92 nutrients, including Vitamin B12, Iodine, Selenium and Vitamin D, in highly absorbable forms, IM8 Daily Essentials is the perfect all-in-one daily multi-vitamin to ensure you meet your daily micronutrient needs. IM8 is offering an exclusive 10% off your first order with a free welcome kit when you enter the promo code SIMON at checkout on im8health.com.
IM8 ships to 27 countries including the U.S., Canada, the U.K., Australia, and many regions across Europe, Asia, and South America.
Upwork
Post your job for free at Upwork.com and connect with top talent ready to help your business grow. Find the right talent to support your business and bring your projects to life.
SwimClub
SwimClub is a science-backed supplement designed to support male fertility, sperm health, and reproductive wellness. Head to swimclub.co to get 25% off your first order with code THEPROOF.
WHOOP
Whoop, the most advanced fitness and health wearable available. Your personalised fitness and health coach to recover faster, sleep better, and train smarter. Claim your first month free on join.whoop.com/simon.
Whoop ships to 56+ international markets, including the US, Canada, most of Europe, Australia, New Zealand, UAE, Singapore, and parts of Asia.


